All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
Economy

Bio-Butadiene Market Estimated to Reach $94 million by 2029 Globally, at...

admin
Pr Newswire

Alvotech and STADA add to Strategic Alliance through Denosumab Partnership

admin
Pr Newswire

Alvotech and STADA add to strategic alliance through denosumab partnership

admin
Economy

Silicon Tetrachloride Market to surpass $3.33 billion by 2031, at a...

admin
Pr Newswire

Bright Peak Therapeutics Announces $90 Million in Series C Financing to...

admin
Pr Newswire

NIRA Dynamics’ Wheel Safety solutions would annually prevent hundreds of accidents...

admin
Economy

Himax to Make Strategic Investment in FOCI Private Placement Financing; Companies...

admin
People

Corn Oil Market to surpass $10.3 Bn by 2032, Says Global...

admin
Pr Newswire

GN to gradually wind-down its Elite and Talk product lines. Strong...

admin
People

Dassault Systèmes: Valeo partners with Dassault Systèmes to accelerate the...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...